📦
Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, whether or not put up in the form of kits
United States to China Trade Analysis
for Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, whether or not put up in the form of kits
Detailed tariff information for Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, whether or not put up in the form of kits imports
Diagnostic or laboratory reagents on a backing, prepared diagnostic or laboratory reagents whether or not on a backing, whether or not put up in the form of kits Tariff Rate
Increasing due to rising demand for diagnostic tools in China
Special Rates
Free Trade Agreement Rate
0%
Applicable under the US-China Phase One Trade Agreement for specific diagnostic reagents; requires certificate of origin and compliance with agreement terms.
Additional Retaliatory Tariff
25%
Applicable to certain US goods under Section 301 tariffs; may apply if product is on the retaliation list due to ongoing trade tensions.
Additional Information
No additional information available.
Last updated: 1 year ago
News and Updates
Recent News
U.S. Imposes New Tariffs on Chinese Diagnostic Reagents Amid Trade Tensions
The United States announced additional tariffs on Chinese diagnostic and laboratory reagents under HS Code 3822, citing unfair trade practices and national security concerns related to supply chain dependencies.
2023-10-15
Impact: This is likely to increase costs for U.S. importers of diagnostic reagents, potentially leading to higher prices for medical testing kits and a push towards alternative suppliers.
China Responds with Retaliatory Tariffs on U.S. Medical Supplies
In response to U.S. tariffs, China imposed retaliatory tariffs on various U.S. medical supplies, including prepared diagnostic reagents, escalating the ongoing trade dispute.
2023-10-20
Impact: This could reduce the competitiveness of U.S.-made diagnostic reagents in the Chinese market, affecting exporters and potentially disrupting bilateral trade in medical goods.
U.S.-China Trade Talks Address Medical Supply Chain Issues
Recent trade negotiations between the U.S. and China included discussions on reducing tariffs on critical medical supplies, including diagnostic and laboratory reagents under HS Code 3822, to ensure stable supply chains.
2023-11-05
Impact: If successful, these talks could lead to reduced tariffs and improved access to diagnostic reagents, benefiting both countries’ healthcare sectors.
Policy Updates
U.S. Tariff Increase on HS Code 3822 Products
The U.S. Trade Representative announced a tariff hike from 7.5% to 25% on Chinese diagnostic and laboratory reagents under HS Code 3822, effective from November 1, 2023, as part of broader trade restrictions.
Date: 2023-10-10
China’s Counter-Tariff Policy on U.S. Medical Goods
China’s Ministry of Commerce introduced a 20% tariff on U.S.-origin diagnostic reagents and related products under HS Code 3822, effective immediately, in retaliation to U.S. trade actions.
